Last reviewed · How we verify
NCT06694896: CNV-MCA
Microarray Application in Newborns With Multiple Congenital Anomalies
NA trial testing Microarray Application in Multiple Abnormalies in 63 participants. Completed in 31 March 2024.
29 November 2023
Quick facts
| Lead sponsor | Konya City Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 63 |
| Start date | 1 December 2022 |
| Primary completion | 29 November 2023 |
| Estimated completion | 31 March 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Microarray Application
Conditions studied
- Multiple Abnormalies — all drugs for Multiple Abnormalies →
Sponsor
Konya City Hospital
Who can join
Adults 1 Day to 30 Days, any sex, with Multiple Abnormalies. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objective: Congenital anomalies are defined as abnormalities of body structure or function that are present at birth and have developed prenatally. Microarray is considered the first-tier diagnostic test for patients with multiple congenital anomalies. The aim of this study is to determine the relationship between microarray results and the phenotype in newborns with multiple congenital anomalies, contribute to patient management by comparing with similar cases in the literature, detect previously unidentified Copy Number Variations (CNV), investigate the hereditary origin of the detected changes, and provide appropriate genetic counseling.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06694896
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Konya City Hospital trials
Trials by the same sponsor.
- NCT07504705 — Comparison of Intertransverse Process and Erector Spinae Plane Blocks in Acute Postoperative Analgesia Management for La · NA · not yet recruiting
- NCT07525167 — Early Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Clinical Data · not yet recruiting
- NCT07335250 — Intertransverse Process Block for Postoperative Analgesia After Thoracotomy and Lobectomy · NA · recruiting
- NCT07511985 — Effect of Rebound Pain on Chronic Postsurgical Pain After Total Knee Arthroplasty · not yet recruiting
- NCT07295158 — Effect of Sevoflurane vs Desflurane on Mechanical Power in Laparoscopic Cholecystectomy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06694896 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Konya City Hospital
- Last refreshed: 19 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06694896.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing